Literature DB >> 5919500

The release of catechol amines by choline 2,6-XYLYL ether, bretylium and guanethidine.

E T Abbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5919500      PMCID： PMC1510786          DOI： 10.1111/j.1476-5381.1966.tb01818.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  23 in total

1.  SUBCELLULAR LOCALIZATION OF CATECHOLAMINES IN TISSUES OF THE RAT.

Authors:  L T POTTER; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

2.  A brief study of the sympathomimetic cardiovascular effects of bretylium.

Authors:  J YELNOSKY; L C MORTIMER
Journal:  Arch Int Pharmacodyn Ther       Date:  1961-02-01

3.  The circul atory effects of bretylium tosylate and guanethidine.

Authors:  S H TAYLOR; K W DONALD
Journal:  Lancet       Date:  1960-08-20       Impact factor: 79.321

4.  Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).

Authors:  R A MAXWELL; A J PLUMMER; F SCHNEIDER; H POVALSKI; A I DANIEL
Journal:  J Pharmacol Exp Ther       Date:  1960-01       Impact factor: 4.030

5.  [Clinical and experimental studies on the hypotensive effect of guanethidine].

Authors:  P LICHTLEN; F SCHAUB; A BUEHLMANN
Journal:  Dtsch Med Wochenschr       Date:  1960-07-09       Impact factor: 0.628

6.  Chromatographic studies of the effect of intravenous injections of tyramine on the concentrations of adrenaline and noradrenaline in plasma.

Authors:  M F LOCKETT; K E EAKINS
Journal:  J Pharm Pharmacol       Date:  1960-09       Impact factor: 3.765

7.  The fluorimetric estimation of adrenaline and noradrenaline during haemorrhagic hypotension.

Authors:  R A MILLAR; B G BENFEY
Journal:  Br J Anaesth       Date:  1958-04       Impact factor: 9.166

8.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

9.  Plasma adrenaline and noradrenaline after phenoxybenzamine administration, and during haemorrhagic hypotension, in normal and adrenalectomized dogs.

Authors:  R A MILLAR; E B KEENER; B G BENFEY
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Tissue amine levels and sympathetic blockade after guanethidine and bretylium.

Authors:  R CASS; T L SPRIGGS
Journal:  Br J Pharmacol Chemother       Date:  1961-12
View more
  7 in total

1.  On the mechanism of the adrenergic nerve blocking action of bretylium.

Authors:  G Haeusler; W Haefely; A Huerlimann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

2.  The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart.

Authors:  E T Abbs; C J Pycock
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

3.  A possible relationship between depletion of noradrenaline and blockade of adrenergic neurones.

Authors:  E T Abbs; M I Robertson
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

4.  Studies on the interactions of guanethidine and bretylium with noradrenaline stores.

Authors:  C C Chang; J C Chang; C Y Su
Journal:  Br J Pharmacol Chemother       Date:  1967-06

5.  The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.

Authors:  E T Abbs; M G Dodd
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

6.  The effect of bretylium on endogenous and newly-synthesized noradrenaline in the microsomal fraction of rat heart.

Authors:  E T Abbs; C J Pycock
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

7.  Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.

Authors:  E T Abbs; M I Robertson
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.